Taron-C DHA By Trigen Laboratories Overview & Drug Interactions

Check For Interactions With Taron-C DHA

Supplement: Taron-C DHA by Trigen Laboratories

Taron-C DHA Label Images

This product contains

Below is a list of the 'active' ingredients listed on the supplement label for this product.

For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.

Drugs that interact with Taron-C DHA by Trigen Laboratories

Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.

Label Information

Supplement Facts:

Daily Value (DV) Target Group(s): Pregnant and Lactating
Minimum serving Sizes:
1 Softgel Capsule(s)
Maximum serving Sizes:
1 Softgel Capsule(s)
Servings per container 30
UPC/BARCODE 313811536300

Ingredient Amount per Serving Group % DV, Adults & children 4+ years
Calories
5 Calorie(s)
Header --
Vitamin C
25 mg
Vitamin C 21%
Ascorbic Acid Precursors
0 NP
Blend
Acid Metabolites
0 NP
Blend
Niacinamide Ascorbate
0 NP
Niacinamide ascorbate
Calcium Ascorbate
0 NP
Calcium Ascorbate
Magnesium Ascorbate
0 NP
Magnesium ascorbate
Potassium Ascorbate
0 NP
Potassium ascorbate
Sodium Ascorbate
0 NP
Sodium Ascorbate
Basic Amino Acids
0 NP
Blend
Lysine Acetate
0 NP
Lysine
Flavonoids
0 NP
Flavonoid (mixture)
Hesperidin
0 NP
Hesperidin
Glutathione
0 NP
Glutathione
Thiamine
2 mg
Vitamin B1 (Thiamine) 143%
Riboflavin
3 mg
Vitamin B2 (Riboflavin) 188%
Niacin
1.8 mg NE
Niacin 10%
Vitamin B6
25 mg
Vitamin B6 1250%
Folate
1667 mcg DFE
Folate 278%
Folic Acid
1000 mcg
Folate
Vitamin B12
12.5 mcg
Vitamin B12 (cyanocobalamin) 446%
Biotin
300 mcg
Biotin 857%
Pantothenic Acid
5 mg
Vitamin B5 (Pantothenic Acid) 71%
Iron
35 mg
Iron 130%
Magnesium
5 mg
Magnesium 1%
Zinc
10 mg
Zinc 77%
Copper
2 mg
Copper 154%
Omega-3 Fatty Acids
200 mg
Omega-3 --
Docosahexaenoic Acid
156 mg
DHA (Docosahexaenoic Acid) --
Eicosapentaenoic Acid
39 mg
EPA (Eicosapentaenoic Acid) --

Other Ingredients:
Bovine Gelatin
Glycerin
yellow Beeswax
Soy Lecithin
Water, Purified
Orange Cream flavor
Sorbitol
Titanium Dioxide
Ethyl Vanillin
FD&C Blue #1


Label Statments:


Formula
- Taron-C DHA with Ascorbic Acid precursors
- Taron - C DHA is a prescription multivitamin/mineral indicated to provide omega-3 fatty acid supplementation throughout pregnancy, during the postnatal period for both lactating and non-lactating mothers, and throughout the childbearing years. Taron - C DHA may be useful in improving the nutritional status of women prior to conception.
FDA Statement of Identity
- Prenatal Multivitamin Supplement
General Statements
- Engineered
- 13811-536-30
Precautions
- This product contains soy and fish (tuna, may include anchovy and/or sardine). Taron - C DHA is contraindicated in patients with a known hypersensitivity to any of the ingredients including soy or fish products.
- Contraindications Taron - C DHA is contraindicated in patients with a known hypersensitivity to any of the ingredients including soy or fish products. All iron compounds are contraindicated in patients with hemochromatosis, hemosiderosis, or hemolytic anemias.
- Warnings Administration of omega-3 fatty acids should be avoided in patients taking anticoagulants and in those known to have an inherited or acquired predisposition to bleeding.
- Warning: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.

Brand Information

See all products by this brand

Manufacturer
Name Trigen Laboratories

Return to the main supplement interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.